ArticleFASEB bioAdvances2025

NPC1L1 Drives Osteoporosis by Activating the C/EBPα/Cyp27a1/27-Hydroxycholesterol Axis: A Novel Therapeutic Target for Bone Loss.

Bohao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.